FIELD: medicine, pharmaceutics.
SUBSTANCE: what is presented is the new chemical compound - a 3-(2,2,2-trimethylhydrazinium)propionate derivative - 3-(2,2,2-trimethylhydrazinium)potassium propionate glycinate, (CH3)3N+NHCH2CH2COOKRCOO-, wherein  exhibiting endothelioprotective activity. The presented derivative can find application in medicine in the integrated treatment for endothelial dysfunction correction in cardiovascular diseases.
 exhibiting endothelioprotective activity. The presented derivative can find application in medicine in the integrated treatment for endothelial dysfunction correction in cardiovascular diseases.
EFFECT: enhanced endothelioprotective properties as compared with previously known mildronat due to the introduction of new functional group showing the most manifested antioxidant properties.
1 tbl
| Title | Year | Author | Number | 
|---|---|---|---|
| 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-BROMNICOTINATE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 | 
 | RU2467745C1 | 
| 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE -3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE NICOTINATE DERIVATIVE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 | 
 | RU2465268C1 | 
| 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE 5-NICOTINATE HYDROXIDE EXHIBITING ENDOTHELIOPROTECTIVE ACTIVITY | 2011 | 
 | RU2467744C1 | 
| 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE DERIVATIVE - POTASSIUM GLYCINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE | 2011 | 
 | RU2457198C1 | 
| 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-NICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 | 
 | RU2458054C1 | 
| 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-BROMNICOTINATE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 | 
 | RU2458690C1 | 
| METHOD OF TADALAFIL-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 | 
 | RU2364395C1 | 
| 3-(2,2,2-TRIMETHYLHYDRAZINIUM) PROPIONATE-5-NICOTINATE HYDROXIDE 3-(2,2,2-TRIMETHYLHYDRAZINIUM) POTASSIUM PROPIONATE DERIVATIVE EXHIBITING ANTIISCHEMIC ACTIVITY | 2011 | 
 | RU2457202C1 | 
| METHOD FOR CORRECTING ENDOTHELIAL DYSFUNCTION WITH COMBINATION OF INDAPAMIDE AND RESVERATROL AT L-NAME-INDUCED DEFICIENCY OF NITROGEN OXIDE | 2005 | 
 | RU2302241C1 | 
| METHOD OF PICAMILONUM-BASED CORRECTION OF ENDOTHELIAL DYSFUNCTION IN L-NAME INDUCED NITRIC OXIDE DEFICIENCY | 2008 | 
 | RU2364393C1 | 
Authors
Dates
2012-11-27—Published
2011-08-08—Filed